Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?
de Graaf
A O
AO
Central Hematology Laboratory, University Medical Center Nijmegen, Nijmegen, The Netherlands.
de Witte
T
T
Jansen
J H
JH
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis; D061945:Caspase Inhibitors; D015972:Gene Expression Regulation, Neoplastic; D019337:Hematologic Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D011506:Proteins / Q000627:therapeutic use*; D015398:Signal Transduction
D000970:Antineoplastic Agents; D061945:Caspase Inhibitors; D051034:Inhibitor of Apoptosis Proteins; D011506:Proteins